Targeted combined therapy in 2D and 3D cultured MCF-7 cells using metformin and erlotinib-loaded mesoporous silica magnetic nanoparticles

References

• Abdolahinia, E.D., et al., 2019. Enhanced penetration and cytotoxicity of metformin and collagenase conjugated gold nanoparticles in breast cancer spheroids. Life sciences, 231, 116545.
   PubMed Web of Science ®Google Scholar
• Aftab, S., et al., 2018. Nanomedicine: an effective tool in cancer therapy. International journal of pharmaceutics, 540 (1–2), 132–149.
   PubMed Web of Science ®Google Scholar
• Aghanejad, A., et al., 2018. Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells. Bioimpacts, 8 (2), 117–127.
   PubMed Web of Science ®Google Scholar
• Akbarzadeh Khiavi, M., et al., 2019. Enzyme-conjugated gold nanoparticles for combined enzyme and photothermal therapy of colon cancer cells. Colloids and surfaces A: Physicochemical and engineering aspects, 572, 333–344.
   Web of Science ®Google Scholar
• Allegra, C., et al., 1986. The effect of methotrexate on intracellular folate pools in human MCF-7 breast cancer cells. Evidence for direct inhibition of purine synthesis. Journal of biological chemistry, 261 (14), 6478–6485.
   PubMed Web of Science ®Google Scholar
• Asgari, D., Aghanejad, A., and Mojarrad, J.S., 2011. An improved convergent approach for synthesis of erlotinib, a tyrosine kinase inhibitor, via a ring closure reaction of phenyl benzamidine intermediate. Bulletin of the Korean chemical society, 32 (3), 909–914.
   Web of Science ®Google Scholar
• Ashkbar, A., et al., 2020. Treatment of breast cancer in vivo by dual photodynamic and photothermal approaches with the aid of curcumin photosensitizer and magnetic nanoparticles. Scientific reports, 10, 21206.
   PubMed Web of Science ®Google Scholar
• Bange, J., Zwick, E., and Ullrich, A., 2001. Molecular targets for breast cancer therapy and prevention. Nature medicine, 7 (5), 548–552.
   PubMed Web of Science ®Google Scholar
• Barghi, L., et al., 2012. Modified Synthesis of Erlotinib Hydrochloride. Advanced pharmaceutical bulletin, 2 (1), 119–122.
   PubMedGoogle Scholar
• Breslin, S., and O’driscoll, L., 2013. Three-dimensional cell culture: the missing link in drug discovery. Drug discovery today, 18 (5-6), 240–249.
   PubMed Web of Science ®Google Scholar
• Chae, Y.K., et al., 2016. Repurposing metformin for cancer treatment: current clinical studies. Oncotarget, 7 (26), 40767–40780.
   PubMed Web of Science ®Google Scholar
• Cheng, W., et al., 2017. pH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy. ACS applied materials & interfaces, 9 (22), 18462–18473.
   PubMed Web of Science ®Google Scholar
• Chou, T., and Martin, N., 2005. CompuSyn for drug combinations: PC software and user’s guide: a computer program for quantitation of synergism and antagonism in drug combinations, and the determination of IC50 and ED50 and LD50 values. Paramus, NJ: ComboSyn.
   Google Scholar
• Costa, E.C., et al., 2018. Spheroids formation on non‐adhesive surfaces by liquid overlay technique: considerations and practical approaches. Biotechnology journal, 13, 1700417.
   Web of Science ®Google Scholar
• Costa, E.C., et al., 2014. Optimization of liquid overlay technique to formulate heterogenic 3D co-cultures models. Biotechnology and bioengineering, 111 (8), 1672–1685.
   PubMed Web of Science ®Google Scholar
• Cui, J., et al., 2015. Engineering poly(ethylene glycol) particles for improved biodistribution. ACS nano, 9 (2), 1571–1580.
   PubMed Web of Science ®Google Scholar
• Dai, Z., et al., 2020. SiO2-coated magnetic nano-Fe3O4 photosensitizer for synergistic tumour-targeted chemo-photothermal therapy. Colloids and surfaces B: biointerfaces, 195, 111274.
   PubMed Web of Science ®Google Scholar
• Das, S.S., et al., 2020. Molecular insights and novel approaches for targeting tumor metastasis. International journal of pharmaceutics, 585, 119556.
   PubMed Web of Science ®Google Scholar
• Deshmukh, A.S., et al., 2017. Polymeric micelles: basic research to clinical practice. International journal of pharmaceutics, 532 (1), 249–268.
   PubMed Web of Science ®Google Scholar
• Di Leo, A., et al., 2015. New approaches for improving outcomes in breast cancer in Europe. Breast, 24 (4), 321–330.
   PubMed Web of Science ®Google Scholar
• Di Veroli, G.Y., et al., 2016. Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics, 32 (18), 2866–2868.
   PubMed Web of Science ®Google Scholar
• Do Amaral, J.B., et al., 2011. MCF-7 cells as a three-dimensional model for the study of human breast cancer. Tissue engineering. Part C, methods, 17 (11), 1097–1107.
   PubMed Web of Science ®Google Scholar
• Fang, Z., et al., 2019. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe3O4 nanoparticles for targeted drug delivery. International journal of nanomedicine, 14, 5785–5797.
   PubMed Web of Science ®Google Scholar
• Fathi, M., et al., 2017. Folate-conjugated thermosensitive O-maleoyl modified chitosan micellar nanoparticles for targeted delivery of erlotinib. Carbohydrate polymers, 172, 130–141.
   PubMed Web of Science ®Google Scholar
• Feng, Y., et al., 2016. The application of mesoporous silica nanoparticle family in cancer theranostics. Coordination chemistry reviews, 319, 86–109.
   Web of Science ®Google Scholar
• Froehlich, K., et al., 2016. Generation of multicellular breast cancer tumor spheroids: comparison of different protocols. Journal of mammary gland biology and neoplasia, 21 (3-4), 89–98.
   PubMed Web of Science ®Google Scholar
• Ganguly, K., Kulkarni, A.R., and Aminabhavi, T.M., 2016. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats. Drug delivery, 23 (8), 2838–2851.
   PubMed Web of Science ®Google Scholar
• Gannimani, R., et al., 2020. Acetal containing polymers as pH-responsive nano-drug delivery systems. Journal of controlled release, 328, 736–761.
   PubMed Web of Science ®Google Scholar
• Gaumet, M., et al., 2008. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. European journal of pharmaceutics and biopharmaceutics, 69 (1), 1–9.
   PubMed Web of Science ®Google Scholar
• Giri, S., et al., 2005. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angewandte chemie, 117 (32), 5166–5172.
   Google Scholar
• Goldman, I.D., and Matherly, L.H., 1985. The cellular pharmacology of methotrexate. Pharmacology and therapeutics, 28 (1), 77–102.
   PubMed Web of Science ®Google Scholar
• Harris, J.M., and Chess, R.B., 2003. Effect of pegylation on pharmaceuticals. Nature reviews. Drug discovery, 2 (3), 214–221.
   PubMed Web of Science ®Google Scholar
• Imamura, Y., et al., 2015. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncology reports, 33 (4), 1837–1843.
   PubMed Web of Science ®Google Scholar
• Kapałczyńska, M., et al., 2018. 2D and 3D cell cultures – a comparison of different types of cancer cell cultures. Archives of medical science, 14 (4), 910–919.
   PubMed Web of Science ®Google Scholar
• Knežević, N.Ž., Gadjanski, I., and Durand, J.-O., 2019. Magnetic nanoarchitectures for cancer sensing, imaging and therapy. Journal of materials chemistry B, 7 (1), 9–23.
   PubMed Web of Science ®Google Scholar
• Kobayashi, K., et al., 2014. Surface engineering of nanoparticles for therapeutic applications. Polymer journal, 46 (8), 460–468.
   Web of Science ®Google Scholar
• Kourelis, T.V., and Siegel, R.D., 2012. Metformin and cancer: new applications for an old drug. Medical oncology, 29 (2), 1314–1327.
   PubMed Web of Science ®Google Scholar
• Lau, Y.-K.I., et al., 2014. Metformin and erlotinib synergize to inhibit basal breast cancer. Oncotarget, 5 (21), 10503–10517.
   PubMedGoogle Scholar
• Li, J., et al., 2013. Multifunctional uniform core-shell Fe3O4@mSiO2 mesoporous nanoparticles for bimodal imaging and photothermal therapy. Chemistry, an Asian journal, 8 (2), 385–391.
   PubMed Web of Science ®Google Scholar
• Li, Z., Zhang, Y., and Feng, N., 2019. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Expert opinion on drug delivery, 16 (3), 219–237.
   PubMed Web of Science ®Google Scholar
• Lu, F., et al., 2009. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small, 5 (12), 1408–1413.
   PubMed Web of Science ®Google Scholar
• Mathews Griner, L.A., et al., 2014. High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proceedings of the national academy of sciences of the united states of america, 111 (6), 2349–2354. https://doi.org/https://doi.org/10.1073/pnas.1311846111.
   Google Scholar
• Miller, K.D., et al., 2020. Cancer statistics for adolescents and young adults, 2020. CA: A cancer journal for clinicians, 70 (6), 443–459.
   PubMed Web of Science ®Google Scholar
• Nabi, P.N., et al., 2021. Mucin-1 conjugated polyamidoamine-based nanoparticles for image-guided delivery of gefitinib to breast cancer. International journal of biological macromolecules, 174, 185–197.
   PubMed Web of Science ®Google Scholar
• Nagelkerke, A., et al., 2013. Generation of multicellular tumor spheroids of breast cancer cells: how to go three-dimensional. Analytical biochemistry, 437 (1), 17–19.
   PubMed Web of Science ®Google Scholar
• Nair, R., et al., 2011. Uptake of FITC labeled silica nanoparticles and quantum dots by rice seedlings: effects on seed germination and their potential as biolabels for plants. Journal of fluorescence, 21 (6), 2057–2068.
   PubMed Web of Science ®Google Scholar
• Nosrati, H., et al., 2018. Methotrexate-conjugated L-lysine coated iron oxide magnetic nanoparticles for inhibition of MCF-7 breast cancer cells. Drug development and industrial pharmacy, 44 (6), 886–894.
   PubMed Web of Science ®Google Scholar
• Patiño-Herrera, R., et al., 2019. Prolonged release of metformin by SiO2 nanoparticles pellets for type II diabetes control. European journal of pharmaceutical sciences, 131, 1–8.
   PubMed Web of Science ®Google Scholar
• Rosenholm, J.M., et al., 2010. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small, 6 (11), 1234–1241.
   PubMed Web of Science ®Google Scholar
• Santra, S., et al., 2004. TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. Chemical communications, 24, 2810–2811.
   PubMed Web of Science ®Google Scholar
• Scaranti, M., et al., 2020. Exploiting the folate receptor α in oncology. Nature reviews clinical oncology, 17 (6), 349–359.
   PubMed Web of Science ®Google Scholar
• Schroeder, M., et al., 2016. Sunitinib treatment reduces tumor growth and limits changes in microvascular properties after minor surgical intervention in an in vivo model of secondary breast cancer growth in bone. Journal of surgical oncology, 113 (5), 515–521.
   PubMed Web of Science ®Google Scholar
• Shah, P.V., and Rajput, S.J., 2018. Facile synthesis of chitosan capped mesoporous silica nanoparticles: a pH responsive smart delivery platform for raloxifene hydrochloride. AAPS PharmSciTech, 19 (3), 1344–1357.
   PubMed Web of Science ®Google Scholar
• Siminzar, P., et al., 2020. Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer. Journal of drug targeting, 28 (1), 92–101.
   PubMed Web of Science ®Google Scholar
• Slowing, I., et al., 2008. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Advanced drug delivery reviews, 60 (11), 1278–1288.
   PubMed Web of Science ®Google Scholar
• Spanheimer, P.M., et al., 2015. Receptor tyrosine kinase expression predicts response to sunitinib in breast cancer. Annals of surgical oncology, 22 (13), 4287–4294.
   PubMed Web of Science ®Google Scholar
• Tan, Z., et al., 2012. Significant systemic therapeutic effects of high-LET immunoradiation by 212Pbtrastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice. International Journal of Oncology, 40 (6), 1881–1888.
   Google Scholar
• Torchilin, V., 2011. Tumor delivery of macromolecular drugs based on the EPR effect. Advanced drug delivery reviews, 63 (3), 131–135.
   PubMed Web of Science ®Google Scholar
• Toss, A., and Cristofanilli, M., 2015. Molecular characterization and targeted therapeutic approaches in breast cancer. Breast cancer research, 17, 60.
   PubMed Web of Science ®Google Scholar
• Truong, D.H., et al., 2020. Delivery of erlotinib for enhanced cancer treatment: an update review on particulate systems. Journal of drug delivery science and technology, 55, 101348.
   Web of Science ®Google Scholar
• Veronese, F.M., and Pasut, G., 2005. PEGylation, successful approach to drug delivery. Drug discovery today, 10 (21), 1451–1458.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2015. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers. European journal of pharmaceutical sciences, 72, 12–20.
   PubMed Web of Science ®Google Scholar
• Wang, A.Z., Langer, R., and Farokhzad, O.C., 2012. Nanoparticle delivery of cancer drugs. Annual review of medicine, 63, 185–198.
   PubMed Web of Science ®Google Scholar
• Wu, H., et al., 2019b. Fe3O4-Based Multifunctional Nanospheres for Amplified Magnetic Targeting Photothermal Therapy and Fenton Reaction. ACS biomaterials science & engineering, 5 (2), 1045–1056.
   PubMed Web of Science ®Google Scholar
• Wu, F., et al., 2019a. Hyaluronic acid-modified porous carbon-coated Fe3O4 nanoparticles for magnetic resonance imaging-guided photothermal/chemotherapy of tumors. Langmuir, 35 (40), 13135–13144.
   PubMed Web of Science ®Google Scholar
• Xiao, K., et al., 2011. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials, 32 (13), 3435–3446.
   PubMed Web of Science ®Google Scholar
• Yang, H., et al., 2020. An NIR-responsive mesoporous silica nanosystem for synergetic photothermal-immunoenhancement therapy of hepatocellular carcinoma. Journal of materials chemistry B, 8 (2), 251–259.
   PubMed Web of Science ®Google Scholar
• Yu, W., et al., 2020. Advances in aggregatable nanoparticles for tumor-targeted drug delivery. Chinese chemical letters, 31 (6), 1366–1374.
   Web of Science ®Google Scholar
• Zhang, L., et al., 2007. Thermo and pH dual‐responsive nanoparticles for anti‐cancer drug delivery. Advanced materials, 19 (19), 2988–2992.
   Web of Science ®Google Scholar